Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma William G. BreenRyan S. YoulandNadia N. Laack Clinical Study 18 May 2022 Pages: 323 - 330
Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma Nikhil RammohanAlexander HoSean Sachdev Research 07 May 2022 Pages: 331 - 339
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas Deborah Y. ParkMartin C. TomErin S. Murphy Research 29 April 2022 Pages: 341 - 348
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI) Krissia M. Rivera PerlaOliver Y. TangAlfredo Quiñones-Hinojosa Clinical Study 03 May 2022 Pages: 349 - 357
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis A. M. ZeitlbergerP. M. PutoraT. Hundsberger Research 29 April 2022 Pages: 359 - 367
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity Carlos Axel López-PérezXochitl Franco-MojicaVictor Garcia Navarro Review 14 May 2022 Pages: 369 - 378
Bone metastasis from glioblastoma: a systematic review Michael J. StrongSravanthi KoduriNicholas J. Szerlip Review 17 May 2022 Pages: 379 - 392
Brachytherapy for central nervous system tumors Evan D. BanderJonathan P. S. KniselyTheodore H. Schwartz Review 11 May 2022 Pages: 393 - 403
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age Huy Gia VuongTam N. M. NgoIan F. Dunn Review 23 May 2022 Pages: 405 - 412
Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy Edmundo Luís Rodrigues PereiraDanielle Cristinne Azevedo FeioRaul Cavalcante Maranhão Research 25 May 2022 Pages: 413 - 421
Long-term hormonal and imaging outcomes of adjunctive gamma knife radiosurgery in non-functioning pituitary adenomas: a single center experience Aasim N. MaldarSanjeev PattankarN. F. Shah Research 20 May 2022 Pages: 423 - 433
Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM) Rehab G. AmerLobna R. Ezz El ArabMenha Swellam Laboratory Investigation Open access 06 June 2022 Pages: 435 - 444
Impact of socio-economic factors on radiation treatment after resection of metastatic brain tumors: trends from a private insurance database David Y. A. DadeyAdrian RodriguesAnand Veeravagu Research 21 May 2022 Pages: 445 - 451
The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts Nancy Ann Oberheim-BushWenyin ShiLeonardo Lustgarten Research Open access 31 May 2022 Pages: 453 - 461
The application of fluorescein sodium for the resection of medulloblastoma Zheng-he ChenXiang-heng ZhangYong-gao Mou Clinical Study Open access 03 June 2022 Pages: 463 - 470
Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era? Assaf BergerKenneth BernsteinDouglas Kondziolka Research 04 June 2022 Pages: 471 - 480
Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition Amy LeHoman MohammadiJames Miller Research 31 May 2022 Pages: 481 - 488
Analysis of factors leading to early termination in glioblastoma-related clinical trials Harshal A. ShahAkash MishraRandy S. D’Amico Review 01 June 2022 Pages: 489 - 495
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study Andres Ramos-FresnedoRicardo A. DomingoWendy J. Sherman Research 14 June 2022 Pages: 497 - 506